Blog
RSS FeedPosted by Michael Wonder on 26 Mar 2017
Federal Government announce 1100 medicines to have prices cut including rosuvastatin
25 March 2017 - Sick Australians will save $500 million over four years and up to $200 a year each ...
Posted by Michael Wonder on 26 Mar 2017
Rare cancer drug added to PBS
25 March 2017 - A drug used to treat a rare form of cancer now widely available through the national ...
Posted by Michael Wonder on 24 Mar 2017
Cost effective but unaffordable: an emerging challenge for health systems
23 March 2017 - New “budget impact test” is an unpopular and flawed attempt to solve a fundamentally political problem ...
Posted by Michael Wonder on 24 Mar 2017
NICE plays key role in European project to help give better care to patients with blood cancers
23 March 2017 - NICE will help improve care for people with blood cancers through a pioneering new partnership. ...
Posted by Michael Wonder on 24 Mar 2017
Bill shock: couple faces $7000 health insurance price rise
25 March 2017 - When NSW couple Edna and Bill Williams were told how much they'd be expected to pay ...
Posted by Michael Wonder on 24 Mar 2017
Hope of B.C. coverage for life-saving cystic fibrosis drug dashed
23 March 2017 - 'It's about dollars,' says father of 16-year-old who claims son's life was changed by access to the ...
Posted by Michael Wonder on 23 Mar 2017
CADTH recommends reimbursement of Stelara for new indication
21 March 2017 - The cost of treatment with ustekinumab should not exceed the drug plan cost of the least costly ...
Posted by Michael Wonder on 23 Mar 2017
Public summary document for Keytruda (pembrolizumab)
22 March 2017 - The public summary document for pembrolizumab for the treatment of patients with non-small-cell lung cancer from the ...
Posted by Michael Wonder on 23 Mar 2017
British Columbia lists Epclusa on public drug plan to treat all six genotypes of chronic hepatitis C infection
21 March 2017 - British Columbia also broadens access for patients with less advanced disease who have other health conditions. ...
Posted by Michael Wonder on 22 Mar 2017
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions
22 March 2017 - Weakly correlated surrogates encourage payers and regulators to impose more stringent evidence thresholds. ...
Posted by Michael Wonder on 22 Mar 2017
Post-menopausal women with a family history of breast cancer should be offered anastrozole, says NICE in updated guidance
22 March 2017 - Post-menopausal women with a family history of breast cancer should be offered anastrozole, NICE has said in ...
Posted by Michael Wonder on 22 Mar 2017
AIA launches insurance to pay huge costs of immunotherapy cancer drugs
22 March 2017 - Immunotherapy drugs can offer patients the chance of beating cancer, but the costs are high. ...
Posted by Michael Wonder on 22 Mar 2017
Medicinal cannabis: MP pushes to make medicinal cannabis cheaper through PBS listing
22 March 2017 - Health Minister Cameron Dick is calling for medicinal cannabis to be subsidised on the Pharmaceutical Benefits ...
Posted by Michael Wonder on 22 Mar 2017
NICE terminates four single technology assessments
22 March 2017 - Appraisals terminated as a result of four sponsors deciding not to submit evidence. ...
Posted by Michael Wonder on 22 Mar 2017
Consumer involvement in their own healthcare – key to a sustainable national health system
21 March 2017 - The Secretary of the Federal Department of Health, Martin Bowles has recognised the importance of consumer involvement ...